American Academy of Otolaryngology-Head and Neck Surgery Foundation Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00695214
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

cevimeline hydrochloride (evoxac) (1 trial)

Drugs in Phase 2 Trials (1)

propofol (diprivan) (1 trial)

Drugs in Other Trials (2)

lactulose (cephulac) (1 trial)

topiramate (topamax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Apnea (Phase 2)

Sleep Apnea, Obstructive (Phase 2)

Sleep Apnea Syndromes (Phase 2)

Xerostomia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4